Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
104 Cards in this Set
- Front
- Back
What is the relationships between patient, dentist, and dental hygienist when coordinating the efforts to attain and maintain the oral health of the patient?
|
Cotherapist
|
|
What are the services within the framework of the total treatment plan to be carried out by the dental hygienist?
|
Dental hygiene care plan
|
|
What is the process of enabling people to increase control and improve their health through self care, mutual aid, and the creation of healthy environments?
|
Health promotion
|
|
What is an action taken by a dental hygienist to maintain or restore a patient's optimal oral health?
|
Intervention
|
|
What is a forecast of the probable course and outcome of the treatment of a condition or disease?
|
Prognosis
|
|
What is the term applied to a legal relationship between dentist and dental team members in practice?
|
Supervision
|
|
What kind of supervision does the dentist diagnose and authorize the condition to be treated, remain on the premises while the procedure is performed, and approves the work performed before dismissal of the patient?
|
Direct Supervision
|
|
What type of supervision has the dentist authorize procedure for a patient of record but does not stay for procedure being carried out but LDH. Treatment is carried out by dentist diagnosis and plan.
|
General Supervision
|
|
What type of supervision does the dentist personally treat patient, but DH can perform a supportive procedure?
|
Personal Supervision
|
|
What are the 5 interrelated roles that DH are found serving?
|
clinician, educator, researcher,administrator/manager, advocate
|
|
ADPIE
|
Assess, diagnose, plan, implement, evaluate
|
|
T/F: Educational and clinical services are mutually independent and separable
|
false; dependent and inseparable
|
|
Who is Dr. Alfred C. Fones?
|
"father of dental hygiene"; emphasizes the importance of education
|
|
Who uses educational theory and methodology to analyze health needs, develops health promotion strategies, and delivers and evaluates the results of attaining or maintaining oral health for individuals or groups?
|
the EDUCATOR
|
|
What refers to measures carried out so that disease does not occur and is truly prevented?
|
Primary Prevention
|
|
What involves the treatment of early disease to prevent further progress of potentially irreversible conditions that can lead to extensive rehabilitative treatment or even loss of teeth?
|
Secondary Prevention
|
|
What uses methods to replace lost tissues and to rehabilitate the oral cavity to a level where function is as near to normal as possible after secondary prevention has not been successful?
|
Tertiary Prevention
|
|
What is obtained by observation and interaction with the patient? ex. CC, perception of health, care and vallue placed on oral health
|
Subjective Data
|
|
What includes physical and oral assessment?
|
Objective Data
|
|
ADPIE role
|
Clinician
|
|
What role in DH applies scientific method to choose therapies, educational methods, or content; interprets and applies findings and solves problems
|
Researcher
|
|
What role in DH applies organizational skills, communicates objectives, identifies and manages resources, and evaluates and modifies programs of health, education, or healthcare?
|
Administrator/Manager
|
|
What role in DH influences legislators, health agencies, and other organizations to bring existing health problems and available resources together to resolve problems and improve access to care.
|
Advocate
|
|
What are dental hygiene therapies or patient educational activities that reduce, eliminate, or prevent the cause of the problem?
|
Determining Interventions
|
|
What represent measurabke criteria for each intervention?
|
Prognosis
|
|
What refers to a learned set of beliefs, values, attitudes, convictions, and behaviors that are common to a group of people and usually passsed down from generation to generation
|
Culture
|
|
What is a set of congruent attitudes, skills, behaviors, and policies that enable effective cross-cultural communication for delivery of oral health services?
|
Cultural competence
|
|
What refers to a dynamic relationship between provider and patient that results in culturally relevant and culturally specific oral healthcare recommendations?
|
Culturally effective oral health care
|
|
What refers to making an effort to understand the language, culture, and behaviors of diverse individuals and groups?
|
Cultural sensativity
|
|
Doing good for a bnenefit or enhanced welfare
|
Beneficence
|
|
basic values of a profession' guide to choices or actions by impling a preference for what is deemed to be acceptable in the profession
|
Core values
|
|
A problem that involves two morally correct choices or courses of action.
|
Ethical Dilemma
|
|
A common problem wherein a solution is readily grounded in the governing practice act, recognized laws, or acceptable standards of care
|
Ethical issue
|
|
A sense of moral obligation' a system of moral principles that governs the conduct of a professional group planned by them for the common good of people' principles of morality
|
Ethics
|
|
avoidance of harm to others; a core value
|
Non maleficence
|
|
a duty to tell the truth when information is disclosed to patients about treatment
|
veracity
|
|
prevention of blood borne pathogens
|
universal precautions
|
|
preventions of other body fluids besides blood (except sweat)
|
standard precautions
|
|
artificially generated collection of particles suspended in air
|
aerosol
|
|
suspension of particles in air that consist partially or wholly of microorganisms
|
microbial aerosol
|
|
what is diminished reactivity to specific antigens inability to react to skin test antigen because of immunosuppression
|
anergy
|
|
response to antigen
|
antibody
|
|
capable of inducing an immune response
|
antigen
|
|
a person who has an infectious agent and serves as a source of infection
|
carrier
|
|
a person who has pathogenic organisms without symptoms
|
asymptomatic carrier
|
|
CDCP
|
United States Centers for Disease Control and Prevention
|
|
CFU
|
colony forming unit
|
|
Communicable period of a disease
|
time when disease can be spread person to person
|
|
particles of moisture expelled while coughing, sneezing, and speaking that may contain infectious agents
|
Droplet
|
|
enzyme linked immunosorbent assay' lab test to detect antibody in blood serum
|
ELISA or EIA
|
|
inanimate object on which disease producing agents may be conveyed
|
fomite
|
|
HCP
|
healthcare personnel
|
|
the microscopic living organisms of a region
|
microbiota
|
|
injection by rout other than alimentary tract
|
parenteral
|
|
4 factors that alter normal defenses
|
physical condition, systemic diseases, drug therapy, prostheses and transplants
|
|
less than 50 micrometers in diameter
|
aerosol
|
|
greater than 50 micrometers in diameter
|
spatter
|
|
Tuberculosis, hepatitis, AIDS, herpes
|
pathogens transmissible by the oral cavity
|
|
a resistant organism that is an AIDS-defining illness; standard precautions are not sufficient to protect DHCP from transmission
|
Tuberculosis
|
|
Incubation period for Tuberculosis
|
as long as 10 weeks
|
|
most commonly occurring Hep, transmitted fecal- oral, incubation period 10 to 50 days, communicable during the 2 to 3 week period before jaundice
|
Hep A
|
|
occurrence has increased in past 20 years, transmitted through blood and other body fluids, incubation period 2-6 months
|
Hep B
|
|
most common blood borne infection in US, can be transmitted through percutaneous exposure to contaminated blood and plasma derivatives, contaminated needles and syringes, transfusion, or accidental needle stick, demonstrated in saliva, tattooing
|
Hep C
|
|
cannot cause infection except in the presence of HBV infection, immunization of Hep B will protect from this,enterically transmitted nonA, non B hep, transmitted by fecal-oral or contaminated water
|
Hep E
|
|
occurs in periodontitis pockets with high prevalence
|
Herpesvirus
|
|
whitlow
|
herpes simplex virus
|
|
varicella-zoster virus
|
chicken pox and shingles
|
|
Epstein-Barr
|
mononucleosis, leukoplakia, periodontal disease severity
|
|
Human herpes virus 7
|
chronic periodontitis
|
|
herpes simplex infection of fingers results from virus entering through minor skin abrasions; mostly around fingers where cracks in skin occur
|
herpetic whitlow
|
|
transmission through blood, semen, vaginal secretions, and breast milk. found in saliva, tears, urine, and bronchial secretions,
|
HIV (human immunodeficiency virus)
|
|
2 to 3 mm red band of gingival margin
|
gingivitis
|
|
ulceration and destruction of interdental papillae with spontaneous bleeding and pain may develop rapidly
|
Necrotizing ulcerative gingivitis
|
|
NUG involving bone
|
Necrotizing ulcerative periodontitis
|
|
clinical hypersensativity state or allergy with a hereditary predisposition
|
atopy
|
|
interoduction of antigenic material or vaccine
|
inoculation
|
|
toxin treated by heat or chemical agent to destroy its deleterious properties
|
toxoid
|
|
test for presence of active or inactive tuberculosis, + test = redness and bump at injection site 2-3 days after injection
|
tuberculosis test
|
|
tetanus & diphtheria immun.
|
3 doses; 1 booster every 10 years
|
|
influenza
|
1 dose annually
|
|
transmission through blood, semen, vaginal secretions, and breast milk. found in saliva, tears, urine, and bronchial secretions,
|
HIV (human immunodeficiency virus)
|
|
2 to 3 mm red band of gingival margin
|
gingivitis
|
|
ulceration and destruction of interdental papillae with spontaneous bleeding and pain may develop rapidly
|
Necrotizing ulcerative gingivitis
|
|
NUG involving bone
|
Necrotizing ulcerative periodontitis
|
|
clinical hypersensativity state or allergy with a hereditary predisposition
|
atopy
|
|
interoduction of antigenic material or vaccine
|
inoculation
|
|
toxin treated by heat or chemical agent to destroy its deleterious properties
|
toxoid
|
|
test for presence of active or inactive tuberculosis, + test = redness and bump at injection site 2-3 days after injection
|
tuberculosis test
|
|
tetanus & diphtheria immun.
|
3 doses; 1 booster every 10 years
|
|
influenza
|
1 dose annually
|
|
Pneumococcal
|
1 dose
|
|
Hep B
|
3 doses (0, 1-2, 4-6 months)
|
|
Hep A
|
2 doses (0, 6-12 months)
|
|
Measles, mumps, rubella (MMR)
|
1 dose if vacc. history is unreliable; 2 doses otherwise
|
|
varicella
|
2 doses (0, 4-8 weeks)
|
|
Meningococcal
|
1 dose
|
|
Face mask filtration
|
greater than 95%
|
|
Types of eyewear (5)
|
goggles, w/ side shields, curved frames, postmydriatic spectacles, child sized
|
|
Resident bacteria
|
stable bacteria
|
|
a microbiologic load, that is, the number of contaminated organisms present on a surface prior to sterilizatio or disinfection
|
bioburden
|
|
EPA
|
United States environmental protection agency
|
|
the joint action of agents so that their combination effect is greater than the sum of their individual parts
|
sunergism
|
|
OSAP
|
Organization for Safety and Asepsis Procedures
|
|
PEP
|
postexposure prophylaxis
|